Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical phase I and II data presented on TMC-435 for hepatitis C

April 15, 2011

Acetone level in exhaled breath as a new biomarker of heart failure

April 15, 2011

Merck & Co. describes new inhibitors of MAP/microtubule affinity-regulating kinase 3

April 15, 2011

TAK-075 is a new, stable, orally active bone anabolic agent for osteoporosis

April 15, 2011

Levels of pentraxin-related protein PTX3 may predict unresponsiveness to IVIG in Kawasaki's disease

April 14, 2011

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

April 14, 2011

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

April 14, 2011

Abbott presents new ROCK-2 inhibitor with high specificity and selectivity

April 14, 2011

Janssen Pharma's new analgesics JNJ-40413269 and JNJ-40534832 show promise in vivo

April 13, 2011

Snapshots: New data on boceprevir in hepatitis C presented at EASL meeting

April 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...